These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Safety, efficacy and control of the menstrual cycle by a monophasic oral contraceptive containing 75 mcg of gestodene and 30 mcg of ethynyl estradiol]. Alvarado Zaldivar G; Ruiz Astorga R; Arenas Arenas M; Solis Carrera L; Rueda Cisneros D; Vázquez Arreola I Ginecol Obstet Mex; 1993 Oct; 61():299-303. PubMed ID: 8270225 [TBL] [Abstract][Full Text] [Related]
10. [The characteristics of triphasic estrogen-progesterone contraceptives and their theoretical indications]. Senèze J Rev Fr Gynecol Obstet; 1990 May; 85(5):301-5. PubMed ID: 2374864 [TBL] [Abstract][Full Text] [Related]
11. Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia. Acta Obstet Gynecol Scand Suppl; 1982; 111():1-60. PubMed ID: 6216716 [No Abstract] [Full Text] [Related]
12. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Jespersen J; Kluft C Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
14. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen. Jespersen J; Nielsen MT Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Bjarnadóttir RI; Tuppurainen M; Killick SR Am J Obstet Gynecol; 2002 Mar; 186(3):389-95. PubMed ID: 11904596 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of the estrogenic effect of ethinylestradiol and mestranol on the endometrium. Brosens IA; Pijnenborg R Contraception; 1976 Dec; 14(6):679-85. PubMed ID: 1017202 [No Abstract] [Full Text] [Related]
17. Estrogen fluctuations, oral contraceptives and borderline personality. DeSoto MC; Geary DC; Hoard MK; Sheldon MS; Cooper L Psychoneuroendocrinology; 2003 Aug; 28(6):751-66. PubMed ID: 12812862 [TBL] [Abstract][Full Text] [Related]
18. Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function. Seeger H; Petersen G; Schulte-Wintrop E; Teichmann AT; Mueck AO Int J Clin Pharmacol Ther; 2002 Apr; 40(4):150-7. PubMed ID: 11996209 [TBL] [Abstract][Full Text] [Related]
20. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study. Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]